135 In the index

Melanotan II nasal MT2-N

A nasal-spray version of Melanotan II, intended to avoid injections. Substances absorbed through the nose tend to work less reliably than injected ones, and no dedicated human studies confirm this spray form actually works as intended.

Also known as Nasal MT2, Melanotan II, Melanotan-II, UPF5CJ93X7, RefChem:925444, MT-II, Melanotan (MT)-II, Melatonan, Melanotan II acetate salt

Effects Libido Skin and hair

Routes Nasal

Legal status Research chemical

WADA Not listed

Molecular Structure of C₅₀H₆₉N₁₅O₉

Drag to rotate · scroll to zoom

Chemistry

Formula: C50H69N15O9
Molar mass: 1024.2
CAS: 121062-08-6
PubChem CID: 92432
IUPAC name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide
InChIKey: JDKLPDJLXHXHNV-MFVUMRCOSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established

Reported range Forum reports of higher doses than injectable to compensate for poor nasal bioavailability

Route Intranasal

Frequency Once or twice daily

Duration Not established

Nasal delivery has poor and inconsistent bioavailability compared to injection; carries the same unregulated-use concerns as injectable Melanotan II.

Where this comes from User-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.